![](https://images.squarespace-cdn.com/content/v1/677585210cb071258cbc9545/d58bda4d-3cd9-4760-8ba8-878093bc2fae/waveedge+background.jpg)
Investment Banking
for Life Sciences
& Healthcare
BOUTIQUE BANK, GLOBAL REACH
Our Sole Focus is Life Sciences & Healthcare
WaveEdge Capital is an independent M&A advisory firm providing tailored sale of company and capital raise services. We work exclusively with companies in the life sciences, healthcare and wellness arenas. Based on decades of experience, we have a deep understanding of the value drivers, business models and varying market dynamics within each niche area.
Our senior team has facilitated deals worth billions of dollars in aggregate transaction value and has extensive relationships with large corporate buyers and private equity investors. To support our clients, we have spent years developing an extensive and focused buyer and investor network specifically targeting these spaces.
To match the preferences of our buyer and investor networks, our focus is primarily on companies in the lower middle market, in general companies with at least $10M in top-line revenue or $2M in EBITDA.
Let us help you construct and facilitate an innovative and optimal transaction solution for your business.
OUR SYSTEMATIC APPROACH
Speaking the language of the target audience takes more than investment banking skills. Our systematic approach is based on more than three decades of life sciences, healthcare and transaction experience.
We help you determine the optimal path and outcome for your company by:
Developing a compelling value proposition for potential acquirers and investors
Educating the market to heighten interest and widen the reach beyond the obvious and traditional buyers; and
Pressure-testing assumptions and bringing deep financial, valuation, structuring and negotiating skills to bear, all to increase the value of your transaction.
Sectors
-
World population is aging and growing wealthier, and healthcare and life sciences spend continues to increase to match it. At the same time, pharma and diagnostics companies are outsourcing an increasing percentage of their R&D and manufacturing functions.
Buyers and investors want to invest in the “picks and shovels” of the healthcare and life sciences industry that supports this growth. This is resulting in an excellent opportunity for companies in this space to grow their companies or complete a successful exit.
WaveEdge advises companies serving the pharma services and life sciences markets with a deep understanding of the markets, operational processes, and business models. We have a large network of buyers and investors who have solid track records in this space and with whom we’re in regular contact.
Companies we work with in this space include:
CROs and CMOs/CDMOs
Clinical & regulatory consulting firms
Pharma packaging and distribution companies
Outsourced commercialization services / CSOs
Specialty life sciences staffing companies
Medical equipment manufacturers and distributors, including durable devices like imaging systems (MRI, CT scanners), surgical instruments, patient monitoring systems, ventilators, and diagnostic devices
R&D equipment and tool companies
Consumables and disposables sourcing, manufacturing and distribution companies, including for reagents, blood products, and single-use diagnostic tests and medical products
-
We are in a particularly opportune time for healthcare services companies:
Demographic shifts resulting in an aging population with a higher prevalence of chronic disease
Ongoing regulatory and reimbursement shift to value-based care
Technology advancement in support of healthcare services to improve access to care, quality, affordability and operational efficiency at unprecedented levels
As a result, we see in our large buyer network a strong and growing interest in investing in this arena.
Companies we work with in this space include:
Medical groups, including physician practice, dental practices and MSOs including risk bearing entities
Home healthcare and hospice groups
Specialist medical centers, including healthcare centers, dialysis, behavioral health, urgent care and imaging
Medical staffing specialists
Assisted living and long term care facilities
Companies providing products and services to all the above
-
The Healthcare IT and HealthTech sectors encompass the technologies, systems, and solutions used to manage, store, share, and analyze healthcare-related data. It integrates information management with healthcare delivery to enhance patient care, operational efficiency, and decision-making.
These systems enable seamless communication among healthcare providers, improve the accuracy of diagnoses, support personalized medicine, and ensure regulatory compliance, such as HIPAA for data privacy. By leveraging advancements like Artificial Intelligence (AI), data analytics, and cloud computing, healthcare IT drives innovation while addressing challenges like interoperability, cybersecurity, and cost containment in the healthcare industry.
Companies we work with in this space include:
Healthcare technology solutions, including EHRs and clinical decision support systems
Health analytics and data management
Medical billing and coding systems
Mobile health apps and patient portals
EHRs, scribe tools and telemedicine platforms
Achieving Optimal Results for our Clients
SELECTED TEAM MEMBER EXPERIENCE
-
John advises healthcare and life sciences companies on M&A, licensing and financial strategy. He also frequently speaks on topics in valuation, deal term benchmarking, and strategy.
Prior to joining WaveEdge, John was a Managing Director at Woodside Capital Partners, a boutique investment bank, where he co-founded and co-led the healthcare and life sciences group. Previously, he was a Principal at Keelin Reeds, a healthcare and life sciences management consulting firm, where he advised dozens of VC-backed and small to mid-cap biopharmaceutical, medical device, and diagnostics companies on M&A, licensing strategies, portfolio management, valuation and strategic direction. He was also an advisor at Strategic Decisions Group (SDG), a global management consulting firm, where he advised many of the top 20 pharmaceutical and medical device companies, as well as Fortune 500 companies in other industries on valuation, business strategy and M&A.
Prior to consulting, John was an attorney with Weil, Gotshal and Manges LLP where he focused on M&A and corporate finance. John holds a JD from Stanford Law School, where he was an Associate Editor of the Law Review, and a BA, magna cum laude, from Brown University, where he was a member of Phi Beta Kappa. (FINRA 7, 24, 63, 79)
-
Jeff brings over 30 years of investment banking and corporate advisory experience to WaveEdge Capital. He started his career in 1980 at Morgan Stanley and later moved to Goldman Sachs, all in NYC. He has participated in over $5B in investment banking transactions and has extensive knowledge of the capital raising and M&A process. In addition, Jeff has advised clients on corporate strategy, business valuation, and a wide range of strategic partnership structures.
Jeff holds an MBA from Dartmouth’s Amos Tuck School of Business Administration (Tuck Scholar) and a BA in Economics from Dartmouth College. He later received an MA in Comparative Philosophy and Religion on the west coast. Jeff was recently named to the Connected Health Conference Advisory Board 2017, a merger of the Partners Connected Health Symposium and the Personal Connected Health Alliance’s Connected Health Conference (formerly the mHealth Summit). Jeff is an avid skier and cyclist and is passionate about philosophy, the history of ideas, poker theory, and global economic analysis. (FINRA 7, 24, 63, 79, 99)
-
Rose serves as Managing Director and focuses on healthcare services. She is also CEO of HealthCAWS, a privately held healthcare services company focused on strategic advisory, M&A and platform tools that impact behaviors and outcomes including as Operating Partner for Pharos Capital and multiple privately held company advisory boards. Rose is an accomplished senior executive having held executive leadership positions at Hartford Hospital, Humana and Magellan Health Services, driving innovation, positive organizational change and results for over 35 years in the healthcare industry. She was a member of Magellan Health’s mergers and acquisition team focused on product and market positioning diligence. She is Chairman of the Board and Chair Emeritus for the Population Health Alliance. She holds a BS in Nursing from St. Joseph College, was critical care certified, and holds an MBA from Rensselaer Polytechnic Institute.
-
Michael brings 25 years of experience as a management consultant and biotech executive. He has led or advised on over 15 closed life sciences transactions, including partnerships, M&A, and investment. His expertise includes corporate, therapeutic area, R&D portfolio, commercial, and business development strategy for dozens of life sciences companies. A recognized expert in life sciences asset valuation, he has served as an expert witness on company valuation and partnership deal terms in multiple litigation cases and regularly presents at major industry conferences.
Prior to WaveEdge, Michael was a Managing Partner at Keelin Reeds Partners, a life sciences-focused management consulting firm. He led Portfolio Strategy and Business Development at Nurix Therapeutics and led Business Development and Strategy at Emulate Therapeutics.
Michael studied biology and management science at Stanford University and has a Master’s degree in Psychology. He is a Fellow in the Society of Decision Professionals.
-
npj Digital Medicine, Editor in Chief
Professor Harvard Medical School
Mass Gen HospitalJoseph C. Kvedar, MD, is creating a new model of healthcare delivery by leveraging personal connected health technologies and remote monitoring tools to better manage chronic conditions, maintain health and wellness, and improve adherence, engagement and clinical outcomes. He is the author of The Internet of Healthy Things, describing how everyday objects will capture and use real-time biometric data to ultimately change behavior to improve our health. Dr. Kvedar created Wellocracy, a leading source of impartial, easy-to-understand information to encourage the sustained use of personal “self-health” technologies.
He is internationally recognized for his leadership and vision in the field of connected health, and has authored over 100 publications on the subject; the popular cHealth Blog provides his insights and vision for connected health. Dr. Kvedar serves as a strategic advisor at Qualcomm Life, Puretech Ventures and BD Technologies, and is a mentor at Blueprint Health, providing guidance and insight to developing companies. Dr. Kvedar is also a mentor at the Harvard Innovation Lab and serves as a judge for its President’s Challenge for Entrepreneurship.
NEWS & EVENTS
Trends. Happenings. Insights.
-
October 2024 - Population Health Innovation and Adoption Summit
Leading Population Health Market Trends for 2024 and Beyond
Keynote: Rose Maljanian
-
August 2024 - Rose Maljanian promoted to Managing Director WaveEdge Capital
-
January 2024 - Rose Maljanian to Chair Healthcare Value Week PHA Roundtable
Emphasizing the importance of population health management strategies to be successful in value based care.
-
October 2023 - Population Health Innovation and Adoption Summit
Leading Population Health Market Trends for 2023 and Beyond
Keynote: Rose Maljanian
-
June 2022 - Private Equity Investors in Private Care
National Primary Care Transformation Summit
Moderator: John Selig -
June 2022 - Valuation and Finance in Life Sciences
BIO International Convention - BD Executive Training Course
Moderator: John Selig
-
June 2022 - Private Equity Investors in Private Care
First Annual PHA State of Population Health
Speaker: Rose Maljanian
-
June 2021 - Valuation and Finance in Life Sciences
BIO International Convention - BD Executive Training Course
Faculty: John Selig
-
October 2020- Investing in Healthcare Services
Population Health Alliance
Panelist: Rose Maljanian
-
July 2020 - Demand for Digital Health Services
WellDoc Panel
Panelist: Rose Maljanian
OUR PARTNERS
Business Partnerships with the Following Organizations
ShareVault offers secure, cloud-based document sharing solutions, also known as virtual data rooms, that are frequently used by organizations of all types to securely share highly confidential documents with outside parties.
-
ShareVault provides enterprise-grade document protection for Virtual Data Rooms. Our built-in software tools speed up organization and collaboration. The result: faster, more efficient outcomes.
Sharevault Website
The Founders of Launchpad Digital Health are on a mission to improve health in the world.
-
The Founders of Launchpad Digital Health are on a mission to improve health in the world. The best way for them to do this is by funding new great companies that can achieve that goal. Ted and Fred have spent their careers funding healthcare and technology companies to improve health. This continues as the driving reason for starting this digital health accelerator.
To augment this effort, the Founders are using 5% of their profits from Launchpad Digital Health to fund micro-lending to small healthcare businesses throughout the world. This enables many new health-related startup businesses with little access to capital to start and thrive. Partnering with Kiva, the largest, most successful microlending platform in the world, is the best way to do this.
This simple commitment from the Founders, Ted and Fred, can change the lives of millions.
To learn more about Launchpad Digital Health, click here.
BROKERCHECK
Check the Background of this Firm on FINRA’s BrokerCheck
Contact Us
Interested in working together? Complete the brief form to the right and we will be in touch shortly. Let us put our extensive experience and expertise to work for you.